Related Experiment Video
Updated: Jul 11, 2025
04:57
Establishing a Competing Risk Regression Nomogram Model for Survival Data
Published on: October 23, 2020
10.2K
Breast Cancer Prognosis: A Study on Mortality Indicators
Chirurgia (Bucharest, Romania : 1990)
|November 15, 2023
Summary
Breast cancer prognosis is improved by identifying key risk factors. This study found tumor size, lymph node status, and specific markers like HER2 predict mortality, aiding clinical treatment decisions.
Area of Science:
- Oncology
- Cancer Research
- Clinical Medicine
Background:
- Accurate breast cancer prognosis is vital for personalized treatment strategies.
- Previous studies identified prognostic markers, but clinical consensus remains elusive.
- This research validates frequent risk factors linked to breast cancer mortality.
Purpose of the Study:
- To validate frequently observed risk factors associated with increased mortality in breast cancer patients.
- To analyze the prognostic value of tumor markers, tumor size, lymph node status, and molecular subtypes.
- To provide insights for clinicians in tailoring breast cancer treatment plans.
Main Methods:
- Retrospective analysis of 213 female patients with Stage IIA-IIIB breast cancer (2014-2020).
- Evaluation of variables including age, disease stage, and treatment type.
- Primary outcome measured by one-year survival rates.
Main Results:
- Elevated preoperative ACE and CA 15-3 levels, larger tumor size, and lymph node invasion correlated with higher mortality.
- Estrogen Receptor (ER) and Progesterone Receptor (PR) positivity were protective; HER2-positive status was a negative prognostic indicator.
- Luminal A subtype showed protective effects, while HER2-positive and Triple-negative subtypes were risk factors.
Conclusions:
- Tumor size, lymph node stage, and specific molecular markers (ER, PR, HER2) significantly predict breast cancer mortality.
- Molecular subtypes (Luminal A, HER2-positive, Triple-negative) play a crucial role in prognosis.
- Findings enhance understanding of breast cancer prognosis and inform clinical management.
More Related Videos
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
296
07:41Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
9.0K
Related Concept Videos
01:21Cancer Survival Analysis
357
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
357
01:24Kaplan-Meier Approach
154
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
154
01:20Comparing the Survival Analysis of Two or More Groups
200
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
200
01:20Actuarial Approach
80
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
80
01:25Statistical Methods for Analyzing Epidemiological Data
382
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
382
01:18Introduction To Survival Analysis
250
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
250